Parkinsonian side effects induced by a monoamine oxidase inhibitor.
Overview
abstract
A 75-year-old depressed woman treated with the monoamine oxidase inhibitor (MAOI) phenelzine developed a parkinsonian syndrome that remitted after discontinuation of the drug. The authors discuss possible explanations for this unusual phenomenon.
